Healthcare-associated pneumonia (HCAP) is a new concept of pneumonia proposed by the
American Thoracic Society/Infectious Diseases Society of America in 2005. This category is …

Aspiration pneumonia is thought to be associated with a poor outcome in patients with
community acquired pneumonia (CAP). However, there has been no systematic review regarding …

The number of senile patients with chronic obstructive pulmonary disease (COPD) has recently
increased due to an increase in life expectancy, the habit of smoking and the inhalation …

Recently, “low-dose and long-term” erythromycin treatment has been reported as effective
on diffuse panbronchiolitis (DPB), but its mechanism is still obscure. Patients with DPB were …

BackgroundHuman herpesvirus 6 (HHV-6) is increasingly recognized as an opportunistic
and potentially life-threatening pathogen in recipients of allogeneic stem cell transplants (SCTs…

Background The epidemiology of human herpesvirus 6 (HHV-6) encephalitis after allogeneic
hematopoietic cell transplantation (HCT) and its relationship with HHV-6 reactivation have …

We measured the levels of interleukin (IL) 1β, tumor necrosis factor alpha, and IL-8 in
bronchoalveolar lavage fluid (BALF) and sera of patients with diffuse panbronchiolitis (DPB) before …

Background and objective Aspiration pneumonia is one of the common presentations of
community‐acquired pneumonia ( CAP ) and healthcare‐associated pneumonia ( HCAP ). …

Background: We analyzed the pharmacokinetic-pharmacodynamic relationship of
vancomycin to determine the drug exposure parameters that correlate with the efficacy and …

The efficacy of low dose long-term erythromycin (EM) therapy in the treatment of chronic lower
respiratory tract disease, including diffuse panbronchiolitis (DPB), has been reported, but …